Showing results (341-350 of 392) with videos related to

Sort By:
Pageof 40
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2023
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumorsWesley S van de Geer, Ron H J Mathijssen, Job van Riet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041)Hanneke W M van Laarhoven, Walter Fiedler, Ingrid M E Desar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant MelanomaMartin Schuler, Lisa Zimmer, Kevin B Kim, et al.
Cancers|June 22, 2023
The Prognostic Relevance of MRI Characteristics in Myxofibrosarcoma Patients Treated with Neoadjuvant RadiotherapyStefan G van Ravensteijn, Maikel J L Nederkoorn, Tom C P Wal, et al.
Targeted Oncology|October 24, 2023
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaAlbiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, et al.
BMC Genomics|January 13, 2006
Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopesTeun W J M van Herpen, Svetlana V Goryunova, Johanna van der Schoot, et al.
ESMO Open|May 1, 2026
Real-world effectiveness of molecular-matched therapies in salivary gland cancerJ A M Weijers, N J van Ruitenbeek, A C H van Engen-van Grunsven, et al.
The Journal of Clinical Investigation|July 19, 2011
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and miceW Joost Lesterhuis, Cornelis J A Punt, Stanleyson V Hato, et al.
Pageof 40